Efficacy and Safety of Changkang Granule in the Treatment of Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)
Status:
Recruiting
Trial end date:
2022-10-30
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate the efficacy and safety of Changkang granule as compared
to placebo over a 8-week treatment period and explore TCM syndrome types.